Trial Profile
A postmarketing surveillance study of solifenacin for the treatment of overactive bladder syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 03 Dec 2015 New trial record